Description
The DoW Prostate Cancer, Early Investigator Research Award supports prostate cancer research conducted by investigators in the early stages of their careers with guidance from an experienced mentor. The award provides funding for a maximum period of 3 years, with a total cost cap of $630,000. The research project must address one of the FY26 PCRP Overarching Challenges, which include improving overall health and wellness for those impacted by prostate cancer, developing new treatments or improving existing therapies to improve outcomes for patients with lethal prostate cancer, enhancing clinical care for all patients with prostate cancer, and defining the biology of prostate cancer progression to lethal prostate cancer.
• The award is open to extramural and intramural U.S. Department of War organizations, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities.
• The Principal Investigator must be an early-career investigator with fewer than three years of postdoctoral research experience.
• The application must include a researcher development plan and a statement of work.
• The award will be granted based on a competitive review process, with selection criteria including the impact of the research, the qualifications of the Principal Investigator and mentor, and the feasibility of the research design and methods.